From MTP Connect Podcast.
In this week’s episode, we chat to WA-based digital health company Artrya’s Co-Founders – CEO John Konstantopoulos and Chairman John Barrington AM – about developing their heart disease detection application, which uses radiology and Artificial Intelligence to more accurately identify patients at risk of Coronary Artery Disease without invasive surgery in a matter of minutes.
The ‘software as a service’ solution will also guide cardiologists to deliver more effective treatment.
Artrya received funding through MTPConnect’s BioMedTech Horizons program.
After starting up two years ago, Artrya have already received TGA registration and are poised to launch pilot programs in WA medical practices.
In this episode they reveal more about their mission to save lives and take their solution around the globe.